Search results
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 5 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling ...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 4 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
3 Things You Need to Know If You Buy Novavax Today
The Motley Fool via AOL· 6 days agoImage source: Getty Images. 1. Novavax's new partnership may supercharge its revenue growth, but don't expect pandemic-level sales Novavax's vaccine...
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 6 days agoPfizer is launching a multi-year cost reduction program expected to include operational efficiencies, network structure changes, and product portfolio...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 6 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 5 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 6 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...
Penn researchers made an avian flu vaccine using a technique that created COVID vaccines
Philly.com· 5 days agoUniversity of Pennsylvania researchers have developed an mRNA vaccine for the H5N1 avian flu drawing...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 4 days agoShares of vaccine stocks Moderna (MRNA 1.58%), Novavax (NVAX 2.31%), and BioNTech SE (BNTX -2.07%)...
Free COVID-19 vaccines could be a thing of the past as federal program is set to expire early
Chicago Sun-Times· 5 days agoWhen COVID-19 vaccines entered the commercial market, the federal government introduced a program to...